User profiles for Joshua J. Meeks

Joshua J. Meeks

Northwestern University, Feinberg School of Medicine
Verified email at northwestern.edu
Cited by 10956

Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline

…, AM Kamat, SP Lerner, Y Lotan, JJ Meeks… - The Journal of …, 2017 - auajournals.org
Purpose : This multidisciplinary, evidence-based guideline for clinically non-metastatic
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of muscle-…

Prostate cancer, version 1.2016

…, MH Kawachi, M Kuettel, RJ Lee, JJ Meeks… - Journal of the National …, 2016 - jnccn.org
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an
initial diagnosis of prostate cancer and management options for localized, regional, and …

[HTML][HTML] An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

…, D Sikic, KEM van Kessel, T Maurer, JJ Meeks… - Nature …, 2021 - nature.com
The molecular landscape in non-muscle-invasive bladder cancer (NMIBC) is characterized
by large biological heterogeneity with variable clinical outcomes. Here, we perform an …

[HTML][HTML] Epidemiology of bladder cancer in 2023: a systematic review of risk factors

…, L Kiemeney, N Lawrentschuk, SP Lerner, JJ Meeks… - European urology, 2023 - Elsevier
Context Bladder cancer (BC) is common worldwide and poses a significant public health
challenge. External risk factors and the wider exposome (totality of exposure from external and …

Pediatric testicular torsion epidemiology using a national database: incidence, risk of orchiectomy and possible measures toward improving the quality of care

LC Zhao, TB Lautz, JJ Meeks, M Maizels - The Journal of urology, 2011 - auajournals.org
Purpose : Testicular torsion causes considerable morbidity in the pediatric population but
the societal burden is poorly quantified. We determined the modern incidence of testicular …

A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer

JJ Meeks, J Bellmunt, BH Bochner, NW Clarke… - European urology, 2012 - Elsevier
CONTEXT: Muscle-invasive bladder cancer (MIBC) is a disease with a pattern of predominantly
distant and early recurrences. Neoadjuvant cisplatin-based combination chemotherapy …

Stricture recurrence after urethroplasty: a systematic review

JJ Meeks, BA Erickson, MA Granieri… - The Journal of …, 2009 - auajournals.org
Purpose : Urethroplasty remains the gold standard for the management of urethral stricture
disease with acceptable long-term success. However, the standard by which stricture …

Bladder cancer, version 5.2017, NCCN clinical practice guidelines in oncology

…, AK Kader, SM Lele, JJ Meeks, J Michalski… - Journal of the National …, 2017 - jnccn.org
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Bladder Cancer focuses on systemic therapy for muscle-invasive urothelial bladder cancer…

NCCN guidelines insights: bladder cancer, version 5.2018

…, AK Kader, SM Lele, JJ Meeks, J Michalski… - Journal of the national …, 2018 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer provide recommendations
for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer. …

[HTML][HTML] 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19

…, JD Cirillo, S Boorjian, PC Black, JJ Meeks… - Nature Reviews …, 2021 - nature.com
Bacillus Calmette–Guérin (BCG) is the most widely used vaccine worldwide and has been
used to prevent tuberculosis for a century. BCG also stimulates an anti-tumour immune …